Zobrazeno 1 - 10
of 153
pro vyhledávání: '"K.G. Babu"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Asian Journal of Oncology, Vol 03, Iss 01, Pp 087-091 (2017)
De novo (pretreatment) epidermal growth factor receptor T790M mutation in non-small-cell lung cancer (NSCLC) is rare when detected by standard genotyping methods. We present a case of concurrent de novo T790M and L858R mutations detected by direct se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b182cfe93d83c3c98077c84bc05679d3
https://doi.org/10.4103/2454-6798.209336
https://doi.org/10.4103/2454-6798.209336
Autor:
M. Bhering, S. Lucien Geater, K. Park, Virote Sriuranpong, V. Pie Jye, S-W. Kim, L. Wang, Ullas Batra, Yirong Wang, C.-T. Yang, B.C. Chul Cho, D-W. Kim, K.G. Babu, K. Amin
Publikováno v:
Annals of Oncology. 31:S864-S865
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbb49c57d848e2d1a75ba65680df86c1
https://doi.org/10.1016/j.annonc.2020.08.1662
https://doi.org/10.1016/j.annonc.2020.08.1662
Autor:
Hemant Malhotra, A. Vora, G. Biswas, K.G. Babu, Gouri Shankar Bhattacharyya, Anantbhushan Ranade, S. Basu
Publikováno v:
Annals of Oncology. 30:v731-v732
Background Patients with carcinoma prostate undergo rapid decline in bone health as measured by bone mineral density in the first 6 to 12 months of treatment with androgen deprivation. The WHO has developed the FRAX (Fracture Risk Assessment) Tool to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6177f82a63c550f41acf89d23c83cc85
https://doi.org/10.1093/annonc/mdz265.042
https://doi.org/10.1093/annonc/mdz265.042
Publikováno v:
Indian journal of cancer. 54(1)
BACKGROUND: Nonsmall cell lung cancer (NSCLC) has varying epidemiological patterns in different countries and also in different regions of each country. In a country with a high prevalence of lung cancer such as India, regional variations in demograp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eead57f337e6275b8bb83be6bf4e83d
https://pubmed.ncbi.nlm.nih.gov/29199703
https://pubmed.ncbi.nlm.nih.gov/29199703
Autor:
L K Rajeev, K.G. Babu, A H Rudresha, M.C.S. Babu, T. Chaudhuri, K C Lakshmaiah, Linu Abraham Jacob, K N Lokesh, L. Dasappa
Publikováno v:
Indian journal of cancer. 54(1)
BACKGROUND: Patients with locally advanced inoperable or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma have a poor prognosis. The maximum benefit of systemic chemotherapy is usually achieved in the first-line setting. Even thou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7313dc16c1a71f2633c0c00135184be4
https://pubmed.ncbi.nlm.nih.gov/29199662
https://pubmed.ncbi.nlm.nih.gov/29199662
Autor:
L K Rajeev, L. Dasappa, A H Rudresha, Linu Abraham Jacob, K N Lokesh, M.C.S. Babu, K.G. Babu, K C Lakshmaiah, T. Chaudhuri
Publikováno v:
Indian journal of cancer. 53(4)
Head and neck squamous cell carcinoma (HNSCC) is now the seventh most common cancer worldwide. The median overall survival for patients with recurrent and/or metastatic (R/M) HNSCC remains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a657e52741001443142a333a60a1fbc
https://pubmed.ncbi.nlm.nih.gov/28485332
https://pubmed.ncbi.nlm.nih.gov/28485332
Autor:
Young-Ae Park, Antonia Ridolfi, Manu Sondhi, Kyung Hwa Jung, Joohyuk Sohn, K.G. Babu, L-M Tseng, S.C. Lee, Juan Pablo Zarate, S.-A. Im, Ioannis Gounaris, Yung-Feng Lu, Yoon Sim Yap, Keun Seok Lee
Publikováno v:
Annals of Oncology. 30:ix15
Background We performed a pooled analysis of Asian pts in the phase III MONALEESA (ML) trials, which tested ET ± RIB in pts with hormone receptor–positive/human epidermal growth factor receptor-2–negative advanced breast cancer. Methods ML-2 and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81803de4c8687ec2f39c54b40ad10eeb
https://doi.org/10.1093/annonc/mdz418.002
https://doi.org/10.1093/annonc/mdz418.002